View Item 

Show simple item record

Trigger Point Injections for Headache Disorders: Expert Consensus Methodology and Narrative Review

dc.contributor.authorRobbins, Matthew S.en_US
dc.contributor.authorKuruvilla, Deenaen_US
dc.contributor.authorBlumenfeld, Andrewen_US
dc.contributor.authorCharleston, Larryen_US
dc.contributor.authorSorrell, Michaelen_US
dc.contributor.authorRobertson, Carrie E.en_US
dc.contributor.authorGrosberg, Brian M.en_US
dc.contributor.authorBender, Steven D.en_US
dc.contributor.authorNapchan, Urien_US
dc.contributor.authorAshkenazi, Avien_US
dc.date.accessioned2014-11-04T16:35:45Z
dc.date.availableWITHHELD_12_MONTHSen_US
dc.date.available2014-11-04T16:35:45Z
dc.date.issued2014-10en_US
dc.identifier.citationRobbins, Matthew S.; Kuruvilla, Deena; Blumenfeld, Andrew; Charleston, Larry; Sorrell, Michael; Robertson, Carrie E.; Grosberg, Brian M.; Bender, Steven D.; Napchan, Uri; Ashkenazi, Avi (2014). "Trigger Point Injections for Headache Disorders: Expert Consensus Methodology and Narrative Review." Headache: The Journal of Head and Face Pain (9): 1441-1459.en_US
dc.identifier.issn0017-8748en_US
dc.identifier.issn1526-4610en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/109332
dc.publisherLippincott Williams & Wilkinsen_US
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherMigraineen_US
dc.subject.otherTrigger Point Injectionen_US
dc.subject.otherHeadacheen_US
dc.subject.otherLocal Anestheticen_US
dc.subject.otherTension‐Typeen_US
dc.subject.otherMyofascial Painen_US
dc.titleTrigger Point Injections for Headache Disorders: Expert Consensus Methodology and Narrative Reviewen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelMedicine (General)en_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/109332/1/head12442.pdf
dc.identifier.doi10.1111/head.12442en_US
dc.identifier.sourceHeadache: The Journal of Head and Face Painen_US
dc.identifier.citedreferenceTfelt‐Hansen P, Pascual J, Ramadan N, et al. Guidelines for controlled trials of drugs in migraine: Third edition. A guide for investigators. Cephalalgia. 2012; 32: 6 ‐ 38.en_US
dc.identifier.citedreferenceAbboud J, Marchand AA, Sorra K, Descarreaux M. Musculoskeletal physical outcome measures in individuals with tension‐type headache: A scoping review. Cephalalgia. 2013; 33: 1319 ‐ 1336.en_US
dc.identifier.citedreferenceShafer N. Pneumothorax following “trigger point” injection. JAMA. 1970; 213: 1193.en_US
dc.identifier.citedreferencePaik NC, Seo JW. CT‐guided needle aspiration of pneumothorax from a trigger point injection. Pain Med. 2011; 12: 837 ‐ 841.en_US
dc.identifier.citedreferenceBotwin KP, Patel BC. Electromyographically guided trigger point injections in the cervicothoracic musculature of obese patients: A new and unreported technique. Pain Physician. 2007; 10: 753 ‐ 756.en_US
dc.identifier.citedreferenceBotwin KP, Sharma K, Saliba R, Patel BC. Ultrasound‐guided trigger point injections in the cervicothoracic musculature: A new and unreported technique. Pain Physician. 2008; 11: 885 ‐ 889.en_US
dc.identifier.citedreferenceFernandez‐de‐Las‐Penas C, Ge HY, Alonso‐Blanco C, Gonzalez‐Iglesias J, Arendt‐Nielsen L. Referred pain areas of active myofascial trigger points in head, neck, and shoulder muscles, in chronic tension type headache. J Bodyw Mov Ther. 2010; 14: 391 ‐ 396.en_US
dc.identifier.citedreferenceFernandez‐de‐Las‐Penas C, Simons D, Cuadrado ML, Pareja J. The role of myofascial trigger points in musculoskeletal pain syndromes of the head and neck. Curr Pain Headache Rep. 2007; 11: 365 ‐ 372.en_US
dc.identifier.citedreferenceGiamberardino MA, Tafuri E, Savini A, et al. Contribution of myofascial trigger points to migraine symptoms. J Pain. 2007; 8: 869 ‐ 878.en_US
dc.identifier.citedreferenceAlvarez DJ, Rockwell PG. Trigger points: Diagnosis and management. Am Fam Physician. 2002; 65: 653 ‐ 660.en_US
dc.identifier.citedreferenceWeiss LD. Easy Injections. Philadelphia: Butterworth‐Heinemann/Elsevier; 2007.en_US
dc.identifier.citedreferenceReeves JL, Jaeger B, Graff‐Radford SB. Reliability of the pressure algometer as a measure of myofascial trigger point sensitivity. Pain. 1986; 24: 313 ‐ 321.en_US
dc.identifier.citedreferenceFischer AA. Pressure algometry over normal muscles. Standard values, validity and reproducibility of pressure threshold. Pain. 1987; 30: 115 ‐ 126.en_US
dc.identifier.citedreferenceHong C‐Z. Considerations and recommendations regarding myofascial trigger point injection. J Musculoskelet Pain. 1994; 2: 29 ‐ 59.en_US
dc.identifier.citedreferenceCheng J, Abdi S. Complications of joint, tendon, and muscle injections. Tech Reg Anesth Pain Manag. 2007; 11: 141 ‐ 147.en_US
dc.identifier.citedreferenceRosenberg PH, Veering BT, Urmey WF. Maximum recommended doses of local anesthetics: A multifactorial concept. Reg Anesth Pain Med. 2004; 29: 564 ‐ 575, discussion 524.en_US
dc.identifier.citedreferenceBecker DE, Reed KL. Local anesthetics: Review of pharmacological considerations. Anesth Prog. 2012; 59: 90 ‐ 101, quiz 102‐103.en_US
dc.identifier.citedreferenceNelson LS, Hoffman RS. Intrathecal injection: Unusual complication of trigger‐point injection therapy. Ann Emerg Med. 1998; 32: 506 ‐ 508.en_US
dc.identifier.citedreferenceElias M. Cervical epidural abscess following trigger point injection. J Pain Symptom Manage. 1994; 9: 71 ‐ 72.en_US
dc.identifier.citedreferenceScott NA, Guo B, Barton PM, Gerwin RD. Trigger point injections for chronic non‐malignant musculoskeletal pain: A systematic review. Pain Med. 2009; 10: 54 ‐ 69.en_US
dc.identifier.citedreferenceCagnie B, Dewitte V, Barbe T, Timmermans F, Delrue N, Meeus M. Physiologic effects of dry needling. Curr Pain Headache Rep. 2013; 17: 348.en_US
dc.identifier.citedreferenceTough EA, White AR, Cummings TM, Richards SH, Campbell JL. Acupuncture and dry needling in the management of myofascial trigger point pain: A systematic review and meta‐analysis of randomised controlled trials. Eur J Pain. 2009; 13: 3 ‐ 10.en_US
dc.identifier.citedreferenceLeroux E, Valade D, Taifas I, et al. Suboccipital steroid injections for transitional treatment of patients with more than two cluster headache attacks per day: A randomised, double‐blind, placebo‐controlled trial. Lancet Neurol. 2011; 10: 891 ‐ 897.en_US
dc.identifier.citedreferenceAmbrosini A, Vandenheede M, Rossi P, et al. Suboccipital injection with a mixture of rapid‐ and long‐acting steroids in cluster headache: A double‐blind placebo‐controlled study. Pain. 2005; 118: 92 ‐ 96.en_US
dc.identifier.citedreferenceChen JT, Chung KC, Hou CR, Kuan TS, Chen SM, Hong CZ. Inhibitory effect of dry needling on the spontaneous electrical activity recorded from myofascial trigger spots of rabbit skeletal muscle. Am J Phys Med Rehabil. 2001; 80: 729 ‐ 735.en_US
dc.identifier.citedreferenceSato A, Sato Y, Shimura M, Uchida S. Calcitonin gene‐related peptide produces skeletal muscle vasodilation following antidromic stimulation of unmyelinated afferents in the dorsal root in rats. Neurosci Lett. 2000; 283: 137 ‐ 140.en_US
dc.identifier.citedreferenceChu J, Schwartz I. The muscle twitch in myofascial pain relief: Effects of acupuncture and other needling methods. Electromyogr Clin Neurophysiol. 2002; 42: 307 ‐ 311.en_US
dc.identifier.citedreferenceNiddam DM, Chan RC, Lee SH, Yeh TC, Hsieh JC. Central modulation of pain evoked from myofascial trigger point. Clin J Pain. 2007; 23: 440 ‐ 448.en_US
dc.identifier.citedreferenceSahai‐Srivastava S, Subhani D. Adverse effect profile of lidocaine injections for occipital nerve block in occipital neuralgia. J Headache Pain. 2010; 11: 519 ‐ 523.en_US
dc.identifier.citedreferenceAshkenazi A, Blumenfeld A, Napchan U, et al. Peripheral nerve blocks and trigger point injections in headache management – a systematic review and suggestions for future research. Headache. 2010; 50: 943 ‐ 952.en_US
dc.identifier.citedreferenceSimons DG, Travell JG, Simons LS. Myofascial Pain and Dysfunction: The Trigger Point Manual, Vol. 1, 2nd edn, Upper Half of Body. Baltimore: Lippincott Williams & Wilkins; 1999.en_US
dc.identifier.citedreferenceSorrell MR. The physical examination of migraine. Curr Pain Headache Rep. 2006; 10: 350 ‐ 354.en_US
dc.identifier.citedreferenceGraff‐Radford SB. Myofascial pain: Diagnosis and management. Curr Pain Headache Rep. 2004; 8: 463 ‐ 467.en_US
dc.identifier.citedreferenceGe HY, Fernandez‐de‐Las‐Penas C, Yue SW. Myofascial trigger points: Spontaneous electrical activity and its consequences for pain induction and propagation. Chin Med. 2011; 6: 13.en_US
dc.identifier.citedreferenceShah JP, Phillips TM, Danoff JV, Gerber LH. An in vivo microanalytical technique for measuring the local biochemical milieu of human skeletal muscle. J Appl Physiol (1985). 2005; 99: 1977 ‐ 1984.en_US
dc.identifier.citedreferenceAlonso‐Blanco C, de‐la‐Llave‐Rincon AI, Fernandez‐de‐las‐Penas C. Muscle trigger point therapy in tension‐type headache. Expert Rev Neurother. 2012; 12: 315 ‐ 322.en_US
dc.identifier.citedreferenceFernandez‐de‐Las‐Penas C, Alonso‐Blanco C, Cuadrado ML, Gerwin RD, Pareja JA. Myofascial trigger points and their relationship to headache clinical parameters in chronic tension‐type headache. Headache. 2006; 46: 1264 ‐ 1272.en_US
dc.identifier.citedreferenceCalandre EP, Hidalgo J, Garcia‐Leiva JM, Rico‐Villademoros F. Trigger point evaluation in migraine patients: An indication of peripheral sensitization linked to migraine predisposition? Eur J Neurol. 2006; 13: 244 ‐ 249.en_US
dc.identifier.citedreferenceCalandre EP, Hidalgo J, Garcia‐Leiva JM, Rico‐Villademoros F, Delgado‐Rodriguez A. Myofascial trigger points in cluster headache patients: A case series. Head Face Med. 2008; 4: 32.en_US
dc.identifier.citedreferenceBlumenfeld A, Ashkenazi A, Grosberg B, et al. Patterns of use of peripheral nerve blocks and trigger point injections among headache practitioners in the USA: Results of the American Headache Society Interventional Procedure Survey (AHS‐IPS). Headache. 2010; 50: 937 ‐ 942.en_US
dc.identifier.citedreferencePeripheral Nerve Blocks and Other Interventional Procedures for Headache and Face Pain Section. In: American Headache Society. http://www.americanheadachesociety.org/members/special_interest_sections/peripheral_nerve_blocks_and_other_interventional_procedures_for_headache_and_face_pain. Accessed August 9, 2013.en_US
dc.identifier.citedreferenceBlumenfeld A, Ashkenazi A, Napchan U, et al. Expert consensus recommendations for the performance of peripheral nerve blocks for headaches – a narrative review. Headache. 2013; 53: 437 ‐ 446.en_US
dc.identifier.citedreferenceCelik D, Mutlu EK. Clinical implication of latent myofascial trigger point. Curr Pain Headache Rep. 2013; 17: 353.en_US
dc.identifier.citedreferenceKaradas O, Gul HL, Inan LE. Lidocaine injection of pericranial myofascial trigger points in the treatment of frequent episodic tension‐type headache. J Headache Pain. 2013; 14: 44.en_US
dc.identifier.citedreferenceHarden RN, Cottrill J, Gagnon CM, et al. Botulinum toxin A in the treatment of chronic tension‐type headache with cervical myofascial trigger points: A randomized, double‐blind, placebo‐controlled pilot study. Headache. 2009; 49: 732 ‐ 743.en_US
dc.identifier.citedreferenceKaradas O, Inan LE, Ulas U, Odabasi Z. Efficacy of local lidocaine application on anxiety and depression and its curative effect on patients withchronic tension‐type headache. Eur Neurol. 2013; 70: 95 ‐ 101.en_US
dc.identifier.citedreferenceFernandez‐de‐Las‐Penas C, Cuadrado ML, Pareja JA. Myofascial trigger points, neck mobility and forward head posture in unilateral migraine. Cephalalgia. 2006; 26: 1061 ‐ 1070.en_US
dc.identifier.citedreferenceAshkenazi A, Young WB. The effects of greater occipital nerve block and trigger point injection on brush allodynia and pain in migraine. Headache. 2005; 45: 350 ‐ 354.en_US
dc.identifier.citedreferenceGarcia‐Leiva JM, Hidalgo J, Rico‐Villademoros F, Moreno V, Calandre EP. Effectiveness of ropivacaine trigger points inactivation in the prophylactic management of patients with severe migraine. Pain Med. 2007; 8: 65 ‐ 70.en_US
dc.identifier.citedreferenceHeadache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013; 33: 629 ‐ 808.en_US
dc.identifier.citedreferenceBaron EP, Cherian N, Tepper SJ. Role of greater occipital nerve blocks and trigger point injections for patients with dizziness and headache. Neurologist. 2011; 17: 312 ‐ 317.en_US
dc.identifier.citedreferencePackard RC. The relationship of neck injury and post‐traumatic headache. Curr Pain Headache Rep. 2002; 6: 301 ‐ 307.en_US
dc.identifier.citedreferenceMarcus DA, Scharff L, Mercer S, Turk DC. Musculoskeletal abnormalities in chronic headache: A controlled comparison of headache diagnostic groups. Headache. 1999; 39: 21 ‐ 27.en_US
dc.identifier.citedreferenceTfelt‐Hansen P, Lous I, Olesen J. Prevalence and significance of muscle tenderness during common migraine attacks. Headache. 1981; 21: 49 ‐ 54.en_US
dc.identifier.citedreferenceJensen K, Tuxen C, Olesen J. Pericranial muscle tenderness and pressure‐pain threshold in the temporal region during common migraine. Pain. 1988; 35: 65 ‐ 70.en_US
dc.identifier.citedreferenceOlesen J. Some clinical features of the acute migraine attack. An analysis of 750 patients. Headache. 1978; 18: 268 ‐ 271.en_US
dc.identifier.citedreferenceFerguson LW, Gerwin R. Clinical Mastery in the Treatment of Myofascial Pain. Philadelphia: Lippincott Williams & Wilkins; 2005.en_US
dc.identifier.citedreferenceGerwin RD, Shannon S, Hong CZ, Hubbard D, Gevirtz R. Interrater reliability in myofascial trigger point examination. Pain. 1997; 69: 65 ‐ 73.en_US
dc.identifier.citedreferenceSimons DG, Mense S. [Diagnosis and therapy of myofascial trigger points]. Schmerz. 2003; 17: 419 ‐ 424.en_US
dc.identifier.citedreferenceLeone M, D'Amico D, Moschiano F, Farinotti M, Filippini G, Bussone G. Possible identification of cervicogenic headache among patients with migraine: An analysis of 374 headaches. Headache. 1995; 35: 461 ‐ 464.en_US
dc.identifier.citedreferenceSjaastad O, Fredriksen TA, Pfaffenrath V. Cervicogenic headache: Diagnostic criteria. Headache. 1990; 30: 725 ‐ 726.en_US
dc.identifier.citedreferenceBiondi DM. Cervicogenic headache: A review of diagnostic and treatment strategies. J Am Osteopath Assoc. 2005; 105: 16S ‐ 22S.en_US
dc.identifier.citedreferenceYanguela J, Pareja JA, Lopez N, Sanchez Del Rio M. Trochleitis and migraine headache. Neurology. 2002; 58: 802 ‐ 805.en_US
dc.identifier.citedreferenceFernandez‐de‐las‐Penas C, Alonso‐Blanco C, Cuadrado ML, Pareja JA. Forward head posture and neck mobility in chronic tension‐type headache: A blinded, controlled study. Cephalalgia. 2006; 26: 314 ‐ 319.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
head12442.pdf
Size:
1.673MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.